Key facts
- This page summarizes Robert B. Shapiro's Form 4 filing for PRECIGEN, INC. (PGEN).
- 3 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 13 Mar 2023, 17:10.
Robert B. Shapiro - 09 Mar 2023 Form 4 Insider Report for PRECIGEN, INC. (PGEN)
- Reporting relationship
- Director
- Issuer ticker
- PGEN
- Reported as of
- 09 Mar 2023
- Net transaction value
- +$31,500
- SEC form
- 4
- Accepted by SEC
- 13 Mar 2023, 17:10:26 UTC
- Prior SEC filing
- 24 Feb 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Robert B. Shapiro, by Donald P. Lehr, as attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Robert B. Shapiro filed Form 4 for PRECIGEN, INC. (PGEN) on 13 Mar 2023.
Change
- Previous filing in this sequence was filed on 24 Feb 2023.
- Current net transaction value: +$31,500.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PGEN
transaction
Common Stock
Award
- Transaction value
- $31,500
- Shares
- +26,923
- Change %
- +8.9%
- Price
- $1.17
- Shares after
- 329,656
- Date
- 09 Mar 2023
- Ownership
- Direct
- Footnotes
- F1
PGEN
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 82,966
- Date
- 09 Mar 2023
- Ownership
- By Trust
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PGEN
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +53,418
- Change %
- Price
- $0.000000
- Shares after
- 53,418
- Date
- 09 Mar 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 53,418
- Exercise price
- Footnotes
- F3, F4
PGEN
transaction
Derivative
Option to Purchase Common Stock (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +130,398
- Change %
- Price
- $0.000000
- Shares after
- 130,398
- Date
- 09 Mar 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 130,398
- Exercise price
- $1.17
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
The shares were issued to the reporting person in lieu of an annual retainer of $31,500.
Footnote F2
Shares held in the Robert B. Shapiro Revocable Trust
Footnote F3
Each restricted stock unit ('RSU") represents a contingent right to receive one share of Precigen common stock.
Footnote F4
The RSUs vest in full on March 9, 2024.